CTKB Cytek Biosciences, Inc.

5.340USD-0.74%Mkt Cap: 694.11M $P/E: —

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lig…

Key Statistics

Company
Market Cap694.11M USD
Enterprise Value463.77M USD
Revenue (TTM)206.71M USD
Gross Profit104.46M USD
Net Income (TTM)-66.54M USD
Revenue/Share1.61 USD
Last Price5.340 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees682
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)76.86
PEG—
EV/EBITDA-11.66
EV/Revenue2.24
P/S3.38
P/B2.17
EPS (TTM)-0.62
EPS (Forward)0.07
52W Range
3.28070% of range6.210
52W High6.210 USD
52W Low3.280 USD
Profitability
Gross Margin51.84%
Oper. Margin-29.50%
EBITDA Margin-19.23%
Profit Margin-33.02%
ROE-19.47%
ROA-14.42%
Growth
Revenue Growth5.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.69M USD
CapEx (TTM)4.19M USD
FCF Margin4.50%
FCF Yield1.34%
Net Debt-235.54M USD
Net Debt/EBITDA5.92
Balance Sheet
Debt/Equity0.07
Current Ratio4.48
Quick Ratio3.71
Book Value/Sh2.48 USD
Cash/Share2.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.563 USD
Upside (mean)+4.2%
Target Range4.750 USD – 7.500 USD
4.750+4.2% to mean7.500
# Analysts4
Ownership
Shares Out.129.98M
Float102.94M
Insiders8.47%
Institutions62.95%
Short Interest
Short Ratio6.3d
Short % Float5.10%
Short % Out.4.03%
Shares Short5.24M
Short (prev mo.)4.99M
Technical
SMA 504.871 (+9.6%)
SMA 2004.620 (+15.6%)
Beta1.16
S&P 52W Chg16.45%
Avg Vol (30d)1.23M
Avg Vol (10d)1.59M
Technical Indicators
RSI (14)50.9
MACD0.2585
MACD Signal0.2899
MACD Hist.-0.0314
BB Upper6.382 USD
BB Middle5.375 USD
BB Lower4.369 USD
BB Width37.44%
ATR (14)0.2890 USD
Vol Ratio (20d)1.22x